NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/01/2025
Back to search
Official data from USPTO
CHEMOPALRX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/02/2025
Trademark type
Word
Nice classes
9
Filing date
09/08/2018
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2025
Last transaction
07/02/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/05/2018
First use in commerce
09/05/2018
Drawing code
4
Owner type
01
Owner location
Van Nuys, CA
Examiner
SWAIN, MICHELE
Current location
Historical data usage
Holders and representatives
Holders
Hung, Kin Wai
Representatives
Hung, Kin Wai
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable software in the nature of a mobile application for allowing physicians to safely and efficiently prescribe chemotherapy on the go
Publications
History of USPTO decisions and trademark events.
36 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2025
ES8R
TEAS SECTION 8 RECEIVED
03/23/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2020
ALIE
ASSIGNED TO LIE
01/24/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/10/2019
GNRT
NON-FINAL ACTION E-MAILED
12/10/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/16/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/15/2019
EX1G
SOU EXTENSION 1 GRANTED
11/15/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/14/2019
IUAF
USE AMENDMENT FILED
11/04/2019
NREV
NOTICE OF REVIVAL - E-MAILED
11/04/2019
EISU
TEAS STATEMENT OF USE RECEIVED
11/04/2019
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
11/04/2019
PETG
PETITION TO REVIVE-GRANTED
11/04/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
11/04/2019
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10/28/2019
ABN6
ABANDONMENT - NO USE STATEMENT FILED
10/28/2019
EXT1
SOU EXTENSION 1 FILED
09/26/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/29/2019
PUBO
PUBLISHED FOR OPPOSITION
01/29/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2018
DOCK
ASSIGNED TO EXAMINER
12/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/17/2018
NWAP
NEW APPLICATION ENTERED
09/12/2018
Continuous trademark protection
Get notified about every new filing that threatens CHEMOPALRX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.